Detalhe da pesquisa
1.
Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia.
Diabetes Obes Metab
; 25(6): 1557-1565, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749303
2.
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial.
Diabetes Obes Metab
; 24(2): 257-267, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643020
3.
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR Trial.
J Am Soc Nephrol
; 32(11): 2900-2911, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551995
4.
Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes.
Diabet Med
; 38(5): e14459, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33179275
5.
Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial.
Diabetes Obes Metab
; 23(2): 561-568, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184931
6.
Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria.
Diabetologia
; 63(12): 2713-2724, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886190
7.
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Lancet
; 393(10184): 1937-1947, 2019 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30995972
8.
Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study.
Diabetologia
; 62(9): 1575-1580, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154479
9.
A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study.
Diabetologia
; 62(1): 147-155, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30293113
10.
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Am J Kidney Dis
; 73(3): 309-315, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30578152
11.
Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials.
Nephrol Dial Transplant
; 34(10): 1699-1706, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184238
12.
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 21(5): 1199-1208, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672083
13.
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
BMC Endocr Disord
; 19(1): 78, 2019 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337371
14.
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study.
Diabetologia
; 61(8): 1724-1733, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29850922
15.
Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.
Diabetologia
; 61(1): 231-241, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101422
16.
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial.
Diabetologia
; 61(3): 581-588, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29098323
17.
Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy.
Am J Kidney Dis
; 71(1): 91-101, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29153995
18.
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
Cardiovasc Diabetol
; 17(1): 50, 2018 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625564
19.
Determining the optimal dose of atrasentan by evaluating the exposure-response relationships of albuminuria and bodyweight.
Diabetes Obes Metab
; 20(8): 2019-2022, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603851
20.
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.
Diabetes Obes Metab
; 20(12): 2899-2904, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987919